

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 5.34097981 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 5.05691223 |
| 3 | * angiotensin maturation (GO:0002003) | 4.95373811 |
| 4 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.60753415 |
| 5 | iron ion import (GO:0097286) | 4.55987473 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 4.43541604 |
| 7 | hormone catabolic process (GO:0042447) | 4.18888798 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.95520701 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.95520701 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.95520701 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.95520701 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.95520701 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.95520701 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.93879247 |
| 15 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.92178847 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90521663 |
| 17 | negative regulation of fatty acid transport (GO:2000192) | 3.81368269 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 3.74843681 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.74267572 |
| 20 | lipoprotein transport (GO:0042953) | 3.73134037 |
| 21 | import into cell (GO:0098657) | 3.70814612 |
| 22 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.68710162 |
| 23 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.63801600 |
| 24 | drug catabolic process (GO:0042737) | 3.58821461 |
| 25 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.54122568 |
| 26 | anterior/posterior axis specification, embryo (GO:0008595) | 3.53061156 |
| 27 | lysine catabolic process (GO:0006554) | 3.52651219 |
| 28 | lysine metabolic process (GO:0006553) | 3.52651219 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.51605185 |
| 30 | negative regulation of sterol transport (GO:0032372) | 3.51215777 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 3.51215777 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.44155783 |
| 33 | positive regulation of macrophage cytokine production (GO:0060907) | 3.43635684 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33711670 |
| 35 | NADH metabolic process (GO:0006734) | 3.33632537 |
| 36 | cysteine metabolic process (GO:0006534) | 3.31979270 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.31562596 |
| 38 | hypotonic response (GO:0006971) | 3.25059178 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.24917322 |
| 40 | lipoprotein metabolic process (GO:0042157) | 3.24609487 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 3.23398936 |
| 42 | positive regulation of lipid catabolic process (GO:0050996) | 3.22177579 |
| 43 | reverse cholesterol transport (GO:0043691) | 3.21229657 |
| 44 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.20574356 |
| 45 | cholesterol efflux (GO:0033344) | 3.19146561 |
| 46 | vitamin A metabolic process (GO:0006776) | 3.17740311 |
| 47 | drug transmembrane transport (GO:0006855) | 3.15104976 |
| 48 | peptide catabolic process (GO:0043171) | 3.13725945 |
| 49 | positive regulation of catenin import into nucleus (GO:0035413) | 3.13628176 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 3.13179785 |
| 51 | midgut development (GO:0007494) | 3.11800022 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.08371491 |
| 53 | negative regulation of cell killing (GO:0031342) | 3.08371491 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.05434829 |
| 55 | epoxygenase P450 pathway (GO:0019373) | 3.05186401 |
| 56 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.04795525 |
| 57 | phospholipid efflux (GO:0033700) | 3.04165897 |
| 58 | flavonoid metabolic process (GO:0009812) | 3.02963104 |
| 59 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.02503529 |
| 60 | virion attachment to host cell (GO:0019062) | 2.96654619 |
| 61 | adhesion of symbiont to host cell (GO:0044650) | 2.96654619 |
| 62 | transepithelial transport (GO:0070633) | 2.95843191 |
| 63 | transcytosis (GO:0045056) | 2.95800424 |
| 64 | positive regulation of fatty acid oxidation (GO:0046321) | 2.95284686 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.95075880 |
| 66 | alpha-linolenic acid metabolic process (GO:0036109) | 2.95022893 |
| 67 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.93215723 |
| 68 | fibril organization (GO:0097435) | 2.92247558 |
| 69 | detection of other organism (GO:0098543) | 2.91921273 |
| 70 | regulation of extracellular matrix disassembly (GO:0010715) | 2.91439160 |
| 71 | sulfur amino acid catabolic process (GO:0000098) | 2.90888357 |
| 72 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.90855240 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 2.89573979 |
| 74 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.89049454 |
| 75 | cellular extravasation (GO:0045123) | 2.87890009 |
| 76 | renal filtration (GO:0097205) | 2.87464491 |
| 77 | glomerular basement membrane development (GO:0032836) | 2.87461517 |
| 78 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87232697 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87232697 |
| 80 | linoleic acid metabolic process (GO:0043651) | 2.85737937 |
| 81 | protein localization to endosome (GO:0036010) | 2.85408908 |
| 82 | hippo signaling (GO:0035329) | 2.84697415 |
| 83 | urea cycle (GO:0000050) | 2.84130312 |
| 84 | urea metabolic process (GO:0019627) | 2.84130312 |
| 85 | embryonic process involved in female pregnancy (GO:0060136) | 2.83948264 |
| 86 | drug transport (GO:0015893) | 2.82501815 |
| 87 | hemidesmosome assembly (GO:0031581) | 2.81774818 |
| 88 | artery development (GO:0060840) | 2.81165935 |
| 89 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.80794684 |
| 90 | protein-lipid complex assembly (GO:0065005) | 2.79149501 |
| 91 | diacylglycerol metabolic process (GO:0046339) | 2.78130835 |
| 92 | response to phenylpropanoid (GO:0080184) | 2.77279183 |
| 93 | regulation of cholesterol esterification (GO:0010872) | 2.75250465 |
| 94 | endodermal cell differentiation (GO:0035987) | 2.72947804 |
| 95 | valine metabolic process (GO:0006573) | 2.72678357 |
| 96 | sterol homeostasis (GO:0055092) | 2.72591069 |
| 97 | skin morphogenesis (GO:0043589) | 2.72320027 |
| 98 | detection of biotic stimulus (GO:0009595) | 2.71105214 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 2.70840161 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 2.70449413 |
| 101 | cholesterol homeostasis (GO:0042632) | 2.70383882 |
| 102 | regulation of macrophage cytokine production (GO:0010935) | 2.70173197 |
| 103 | cell migration involved in heart development (GO:0060973) | 2.69337336 |
| 104 | intestinal epithelial cell development (GO:0060576) | 2.66461306 |
| 105 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65827355 |
| 106 | response to host immune response (GO:0052572) | 2.65827355 |
| 107 | fatty acid beta-oxidation (GO:0006635) | 2.64726735 |
| 108 | endocardial cushion development (GO:0003197) | 2.64013251 |
| 109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64006370 |
| 110 | response to host (GO:0075136) | 2.64006370 |
| 111 | response to host defenses (GO:0052200) | 2.64006370 |
| 112 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.62692096 |
| 113 | apoptotic cell clearance (GO:0043277) | 2.62633198 |
| 114 | adhesion of symbiont to host (GO:0044406) | 2.61556674 |
| 115 | protein heterotrimerization (GO:0070208) | 2.61529085 |
| 116 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.60816704 |
| 117 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.60487543 |
| 118 | cellular modified amino acid catabolic process (GO:0042219) | 2.59308305 |
| 119 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.58023282 |
| 120 | protein-lipid complex remodeling (GO:0034368) | 2.57925374 |
| 121 | macromolecular complex remodeling (GO:0034367) | 2.57925374 |
| 122 | plasma lipoprotein particle remodeling (GO:0034369) | 2.57925374 |
| 123 | multicellular organismal catabolic process (GO:0044243) | 2.57859503 |
| 124 | extracellular fibril organization (GO:0043206) | 2.57666907 |
| 125 | triglyceride biosynthetic process (GO:0019432) | 2.56964331 |
| 126 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.55621694 |
| 127 | glomerular filtration (GO:0003094) | 2.54243161 |
| 128 | amino-acid betaine metabolic process (GO:0006577) | 2.53884757 |
| 129 | cholesterol transport (GO:0030301) | 2.53825952 |
| 130 | sterol transport (GO:0015918) | 2.53825952 |
| 131 | modified amino acid transport (GO:0072337) | 2.52863114 |
| 132 | COPII vesicle coating (GO:0048208) | 2.52396705 |
| 133 | positive regulation of histone deacetylation (GO:0031065) | 2.51096963 |
| 134 | triglyceride catabolic process (GO:0019433) | 2.50660384 |
| 135 | regulation of bile acid biosynthetic process (GO:0070857) | 2.49505952 |
| 136 | sulfate transmembrane transport (GO:1902358) | 2.49048654 |
| 137 | ethanol oxidation (GO:0006069) | 2.48620543 |
| 138 | multicellular organismal metabolic process (GO:0044236) | 2.48348588 |
| 139 | nitrogen cycle metabolic process (GO:0071941) | 2.48340112 |
| 140 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.48162277 |
| 141 | short-chain fatty acid metabolic process (GO:0046459) | 2.48124778 |
| 142 | drug metabolic process (GO:0017144) | 2.46933011 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.46589538 |
| 144 | fatty acid oxidation (GO:0019395) | 2.45903150 |
| 145 | collagen fibril organization (GO:0030199) | 2.44589465 |
| 146 | basement membrane organization (GO:0071711) | 2.44382075 |
| 147 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.43578417 |
| 148 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.43235257 |
| 149 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.43084035 |
| 150 | carnitine shuttle (GO:0006853) | 2.41247795 |
| 151 | glomerular visceral epithelial cell development (GO:0072015) | 2.40661813 |
| 152 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.40655316 |
| 153 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.40375987 |
| 154 | negative regulation of cell fate specification (GO:0009996) | 2.40299314 |
| 155 | bone morphogenesis (GO:0060349) | 2.40059348 |
| 156 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39980525 |
| 157 | lipid oxidation (GO:0034440) | 2.38876177 |
| 158 | prostate gland epithelium morphogenesis (GO:0060740) | 2.38137616 |
| 159 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.38129768 |
| 160 | neutral lipid biosynthetic process (GO:0046460) | 2.38093558 |
| 161 | acylglycerol biosynthetic process (GO:0046463) | 2.38093558 |
| 162 | extracellular matrix assembly (GO:0085029) | 2.35387051 |
| 163 | detection of bacterium (GO:0016045) | 2.35091964 |
| 164 | growth hormone receptor signaling pathway (GO:0060396) | 2.34794443 |
| 165 | regulation of sequestering of triglyceride (GO:0010889) | 2.34595165 |
| 166 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.34476551 |
| 167 | blood vessel maturation (GO:0001955) | 2.32984869 |
| 168 | tooth mineralization (GO:0034505) | 2.32379094 |
| 169 | response to peptidoglycan (GO:0032494) | 2.31455797 |
| 170 | positive regulation of receptor recycling (GO:0001921) | 2.31199817 |
| 171 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.31180074 |
| 172 | chondrocyte development (GO:0002063) | 2.30373668 |
| 173 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.29763318 |
| 174 | negative regulation of type 2 immune response (GO:0002829) | 2.28989588 |
| 175 | collagen metabolic process (GO:0032963) | 2.28770605 |
| 176 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.28501992 |
| 177 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.28500410 |
| 178 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.28500410 |
| 179 | macrophage activation (GO:0042116) | 2.28318631 |
| 180 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.28014271 |
| 181 | bone trabecula formation (GO:0060346) | 2.25600622 |
| 182 | dendritic cell migration (GO:0036336) | 2.24390358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.17474769 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.04527427 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34643874 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.32332597 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.28753682 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.24942770 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15529561 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.96462438 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.93714433 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.88610617 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.62927174 |
| 12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.48635846 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37896353 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36669903 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.32773356 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.30885744 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.25250896 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25137303 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17611659 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.16702234 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15709161 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.13038698 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07869532 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05483214 |
| 25 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.03294194 |
| 26 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.01283904 |
| 27 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.00326078 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.97668160 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.96346723 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.91003355 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88503792 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87794792 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85646207 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85372462 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.83479308 |
| 36 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.75172529 |
| 37 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.73749843 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72100970 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.71470100 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70679350 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70194941 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69608606 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69534230 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68217827 |
| 45 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.67861024 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67586178 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64566733 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63823618 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63052953 |
| 50 | * SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.57767509 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56985619 |
| 52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56489458 |
| 53 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.55811799 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54951946 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53648758 |
| 56 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.53112578 |
| 57 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.52934819 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51622803 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.50643007 |
| 60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.49622731 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45899727 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42915808 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41166870 |
| 64 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41038447 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39638254 |
| 66 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38409714 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38109440 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36464971 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36111123 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35717316 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34136243 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33836857 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.33337803 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31504086 |
| 75 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31193150 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29659224 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27952221 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27719320 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26010957 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25819766 |
| 81 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.24701760 |
| 82 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.24701760 |
| 83 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.24701760 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24615183 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23838512 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22718033 |
| 87 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.22240207 |
| 88 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21696411 |
| 89 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.21588896 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21444084 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20945185 |
| 92 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20161846 |
| 93 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19756225 |
| 94 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.19013397 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18950809 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18950809 |
| 97 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.18594760 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18357593 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17907649 |
| 100 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17900360 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17815045 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16920758 |
| 103 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16541838 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14864170 |
| 105 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14497236 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12927699 |
| 107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12838220 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11652231 |
| 109 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.11597879 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10615963 |
| 111 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10450920 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09459623 |
| 113 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.08468300 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08372773 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08372773 |
| 116 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07971325 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07971325 |
| 118 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07776177 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07767860 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07604085 |
| 121 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.05260543 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05225925 |
| 123 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.05128251 |
| 124 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04396253 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04227341 |
| 126 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02666096 |
| 127 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01069380 |
| 128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01016566 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99710232 |
| 130 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99452086 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98746296 |
| 132 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98674824 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98535605 |
| 134 | MYB_26560356_Chip-Seq_TH1_Human | 0.97420978 |
| 135 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.97204987 |
| 136 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96555940 |
| 137 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.96467646 |
| 138 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.96381736 |
| 139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96268001 |
| 140 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96244172 |
| 141 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96217166 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95514056 |
| 143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95485352 |
| 144 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95032027 |
| 145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94247646 |
| 146 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93890496 |
| 147 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93796449 |
| 148 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93678024 |
| 149 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93521030 |
| 150 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93087093 |
| 151 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93073675 |
| 152 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92275002 |
| 153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91708099 |
| 154 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90727968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.98838408 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.19996436 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.96545685 |
| 4 | MP0004858_abnormal_nervous_system | 3.44514463 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.30777844 |
| 6 | MP0005451_abnormal_body_composition | 3.11115105 |
| 7 | MP0003252_abnormal_bile_duct | 3.10703507 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.05215097 |
| 9 | MP0003724_increased_susceptibility_to | 2.95154950 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.88234463 |
| 11 | MP0000537_abnormal_urethra_morphology | 2.83652271 |
| 12 | MP0005275_abnormal_skin_tensile | 2.64622160 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.60807357 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.41125203 |
| 15 | MP0005365_abnormal_bile_salt | 2.34086339 |
| 16 | MP0003279_aneurysm | 2.31120324 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.30995301 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.23932817 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.22688035 |
| 20 | MP0004272_abnormal_basement_membrane | 2.14872203 |
| 21 | MP0009384_cardiac_valve_regurgitation | 2.14155746 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.99488833 |
| 23 | MP0003436_decreased_susceptibility_to | 1.81962552 |
| 24 | MP0000566_synostosis | 1.79570035 |
| 25 | MP0000462_abnormal_digestive_system | 1.77054382 |
| 26 | MP0009053_abnormal_anal_canal | 1.73924501 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.72718704 |
| 28 | MP0003091_abnormal_cell_migration | 1.71603337 |
| 29 | MP0002254_reproductive_system_inflammat | 1.70666199 |
| 30 | MP0005332_abnormal_amino_acid | 1.69691670 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.68526796 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.67361929 |
| 33 | MP0000534_abnormal_ureter_morphology | 1.61325828 |
| 34 | MP0005164_abnormal_response_to | 1.57084331 |
| 35 | MP0001542_abnormal_bone_strength | 1.50000624 |
| 36 | MP0002971_abnormal_brown_adipose | 1.49724483 |
| 37 | MP0008260_abnormal_autophagy | 1.48215113 |
| 38 | MP0004130_abnormal_muscle_cell | 1.47875227 |
| 39 | MP0004883_abnormal_blood_vessel | 1.44863518 |
| 40 | MP0003828_pulmonary_edema | 1.41601922 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.40039428 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.39856178 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.38306934 |
| 44 | MP0001958_emphysema | 1.36084246 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.35591796 |
| 46 | MP0004043_abnormal_pH_regulation | 1.34523485 |
| 47 | MP0005248_abnormal_Harderian_gland | 1.33663244 |
| 48 | * MP0004947_skin_inflammation | 1.31711467 |
| 49 | MP0000685_abnormal_immune_system | 1.31514975 |
| 50 | MP0005409_darkened_coat_color | 1.30624252 |
| 51 | MP0009785_altered_susceptibility_to | 1.29241134 |
| 52 | MP0006054_spinal_hemorrhage | 1.27314514 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.27308713 |
| 54 | MP0003941_abnormal_skin_development | 1.25700700 |
| 55 | MP0009840_abnormal_foam_cell | 1.25384616 |
| 56 | MP0002006_tumorigenesis | 1.24613451 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.24136853 |
| 58 | MP0002896_abnormal_bone_mineralization | 1.23078760 |
| 59 | MP0010030_abnormal_orbit_morphology | 1.20736290 |
| 60 | MP0002419_abnormal_innate_immunity | 1.20534660 |
| 61 | MP0003385_abnormal_body_wall | 1.19233044 |
| 62 | MP0002132_abnormal_respiratory_system | 1.17839773 |
| 63 | MP0000762_abnormal_tongue_morphology | 1.16943164 |
| 64 | MP0010678_abnormal_skin_adnexa | 1.15563489 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.15464327 |
| 66 | MP0003448_altered_tumor_morphology | 1.14890522 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.14270561 |
| 68 | MP0000516_abnormal_urinary_system | 1.13701575 |
| 69 | MP0005367_renal/urinary_system_phenotyp | 1.13701575 |
| 70 | MP0001849_ear_inflammation | 1.13366212 |
| 71 | MP0002796_impaired_skin_barrier | 1.12167840 |
| 72 | MP0003283_abnormal_digestive_organ | 1.09156703 |
| 73 | MP0003937_abnormal_limbs/digits/tail_de | 1.08339207 |
| 74 | MP0001756_abnormal_urination | 1.06677578 |
| 75 | MP0000767_abnormal_smooth_muscle | 1.06004222 |
| 76 | MP0001346_abnormal_lacrimal_gland | 1.04775092 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.04480658 |
| 78 | MP0010386_abnormal_urinary_bladder | 1.04377728 |
| 79 | MP0000858_altered_metastatic_potential | 1.04173266 |
| 80 | MP0001243_abnormal_dermal_layer | 1.03949164 |
| 81 | MP0002060_abnormal_skin_morphology | 1.03480676 |
| 82 | MP0006082_CNS_inflammation | 1.03211796 |
| 83 | MP0009250_abnormal_appendicular_skeleto | 1.03030589 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 1.02330197 |
| 85 | MP0003942_abnormal_urinary_system | 1.01596910 |
| 86 | MP0005647_abnormal_sex_gland | 1.01290844 |
| 87 | MP0005390_skeleton_phenotype | 0.99171957 |
| 88 | MP0002009_preneoplasia | 0.98294625 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.97066015 |
| 90 | MP0005166_decreased_susceptibility_to | 0.96436185 |
| 91 | MP0005025_abnormal_response_to | 0.95601987 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.95480033 |
| 93 | MP0003868_abnormal_feces_composition | 0.94534653 |
| 94 | MP0004233_abnormal_muscle_weight | 0.94322329 |
| 95 | MP0003303_peritoneal_inflammation | 0.94028482 |
| 96 | MP0009115_abnormal_fat_cell | 0.92085663 |
| 97 | MP0003045_fibrosis | 0.91926325 |
| 98 | MP0006138_congestive_heart_failure | 0.91805131 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.90778633 |
| 100 | MP0000609_abnormal_liver_physiology | 0.90498691 |
| 101 | MP0002115_abnormal_skeleton_extremities | 0.90279202 |
| 102 | MP0003950_abnormal_plasma_membrane | 0.89912403 |
| 103 | MP0005023_abnormal_wound_healing | 0.89587934 |
| 104 | MP0000163_abnormal_cartilage_morphology | 0.89416267 |
| 105 | MP0000613_abnormal_salivary_gland | 0.89104454 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.88901770 |
| 107 | MP0003806_abnormal_nucleotide_metabolis | 0.88560306 |
| 108 | MP0005377_hearing/vestibular/ear_phenot | 0.88010871 |
| 109 | MP0003878_abnormal_ear_physiology | 0.88010871 |
| 110 | MP0002396_abnormal_hematopoietic_system | 0.87145546 |
| 111 | MP0009697_abnormal_copulation | 0.86856376 |
| 112 | MP0005000_abnormal_immune_tolerance | 0.86249186 |
| 113 | MP0001790_abnormal_immune_system | 0.85666623 |
| 114 | MP0005387_immune_system_phenotype | 0.85666623 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.85196761 |
| 116 | MP0003075_altered_response_to | 0.85068524 |
| 117 | MP0002249_abnormal_larynx_morphology | 0.83763479 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.82825899 |
| 119 | MP0002098_abnormal_vibrissa_morphology | 0.82326060 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.82257819 |
| 121 | MP0001800_abnormal_humoral_immune | 0.81921783 |
| 122 | MP0000249_abnormal_blood_vessel | 0.79643118 |
| 123 | MP0002111_abnormal_tail_morphology | 0.79544488 |
| 124 | MP0002168_other_aberrant_phenotype | 0.79118135 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.78358138 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.77358147 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.76860091 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.76311488 |
| 129 | MP0005076_abnormal_cell_differentiation | 0.75167815 |
| 130 | MP0003115_abnormal_respiratory_system | 0.75038906 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.74383784 |
| 132 | MP0003195_calcinosis | 0.74110603 |
| 133 | MP0003795_abnormal_bone_structure | 0.73886508 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.73583000 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.73496276 |
| 136 | MP0005508_abnormal_skeleton_morphology | 0.73411654 |
| 137 | MP0003755_abnormal_palate_morphology | 0.72024875 |
| 138 | MP0003935_abnormal_craniofacial_develop | 0.71712667 |
| 139 | MP0002133_abnormal_respiratory_system | 0.70744709 |
| 140 | MP0005388_respiratory_system_phenotype | 0.70744709 |
| 141 | MP0008004_abnormal_stomach_pH | 0.70325629 |
| 142 | MP0002452_abnormal_antigen_presenting | 0.69959062 |
| 143 | MP0000477_abnormal_intestine_morphology | 0.69438864 |
| 144 | MP0002723_abnormal_immune_serum | 0.69265912 |
| 145 | MP0002282_abnormal_trachea_morphology | 0.69121314 |
| 146 | MP0005464_abnormal_platelet_physiology | 0.68977497 |
| 147 | MP0002108_abnormal_muscle_morphology | 0.68890773 |
| 148 | MP0002876_abnormal_thyroid_physiology | 0.68783582 |
| 149 | MP0004885_abnormal_endolymph | 0.68257172 |
| 150 | MP0000569_abnormal_digit_pigmentation | 0.67619046 |
| 151 | MP0005670_abnormal_white_adipose | 0.67565483 |
| 152 | MP0003959_abnormal_lean_body | 0.67556992 |
| 153 | MP0003315_abnormal_perineum_morphology | 0.67079390 |
| 154 | MP0002932_abnormal_joint_morphology | 0.66256135 |
| 155 | MP0002138_abnormal_hepatobiliary_system | 0.64079809 |
| 156 | MP0001299_abnormal_eye_distance/ | 0.63956713 |
| 157 | MP0004782_abnormal_surfactant_physiolog | 0.63493423 |
| 158 | MP0000432_abnormal_head_morphology | 0.63289270 |
| 159 | MP0001177_atelectasis | 0.63265078 |
| 160 | MP0005501_abnormal_skin_physiology | 0.62179824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.74026229 |
| 2 | Peritonitis (HP:0002586) | 4.70722079 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 4.19642328 |
| 4 | Hydroxyprolinuria (HP:0003080) | 4.19642328 |
| 5 | Hyperglycinuria (HP:0003108) | 3.81196180 |
| 6 | Vascular tortuosity (HP:0004948) | 3.61449785 |
| 7 | Facial shape deformation (HP:0011334) | 3.53449493 |
| 8 | Potter facies (HP:0002009) | 3.53449493 |
| 9 | Soft skin (HP:0000977) | 3.35659519 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 3.28218886 |
| 11 | Dilatation of the ascending aorta (HP:0005111) | 3.26659417 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 3.25770695 |
| 13 | Protrusio acetabuli (HP:0003179) | 3.25199763 |
| 14 | Ankle contracture (HP:0006466) | 3.22433614 |
| 15 | Increased variability in muscle fiber diameter (HP:0003557) | 3.18091716 |
| 16 | Blue sclerae (HP:0000592) | 3.17429505 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.02028508 |
| 18 | Overgrowth (HP:0001548) | 2.95460052 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 2.95384040 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.95384040 |
| 21 | Thin bony cortex (HP:0002753) | 2.93640960 |
| 22 | Slender build (HP:0001533) | 2.92859484 |
| 23 | Vertebral compression fractures (HP:0002953) | 2.91932866 |
| 24 | Sparse lateral eyebrow (HP:0005338) | 2.90990867 |
| 25 | Bladder diverticulum (HP:0000015) | 2.89657198 |
| 26 | Widely patent fontanelles and sutures (HP:0004492) | 2.86727748 |
| 27 | Arterial tortuosity (HP:0005116) | 2.85439700 |
| 28 | Atrophic scars (HP:0001075) | 2.81532066 |
| 29 | Mesangial abnormality (HP:0001966) | 2.81372071 |
| 30 | Genu recurvatum (HP:0002816) | 2.80025919 |
| 31 | Rectal prolapse (HP:0002035) | 2.79596882 |
| 32 | Lymphangioma (HP:0100764) | 2.75734551 |
| 33 | Wormian bones (HP:0002645) | 2.75620888 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.73116734 |
| 35 | Aortic aneurysm (HP:0004942) | 2.72966555 |
| 36 | Fat malabsorption (HP:0002630) | 2.70147324 |
| 37 | Cupped ribs (HP:0000887) | 2.64948353 |
| 38 | Osteolytic defects of the hand bones (HP:0009699) | 2.62513196 |
| 39 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62513196 |
| 40 | Malnutrition (HP:0004395) | 2.60899061 |
| 41 | Shallow orbits (HP:0000586) | 2.59507302 |
| 42 | Wide cranial sutures (HP:0010537) | 2.58971782 |
| 43 | Aortic dissection (HP:0002647) | 2.58834031 |
| 44 | Ileus (HP:0002595) | 2.58644986 |
| 45 | Premature rupture of membranes (HP:0001788) | 2.57045048 |
| 46 | Gastrointestinal infarctions (HP:0005244) | 2.56637611 |
| 47 | Broad metatarsal (HP:0001783) | 2.55649362 |
| 48 | Gingivitis (HP:0000230) | 2.52138359 |
| 49 | Orchitis (HP:0100796) | 2.50590851 |
| 50 | Xanthomatosis (HP:0000991) | 2.49602928 |
| 51 | Focal segmental glomerulosclerosis (HP:0000097) | 2.49198848 |
| 52 | Abnormality of the 2nd finger (HP:0004100) | 2.49189457 |
| 53 | Wide anterior fontanel (HP:0000260) | 2.44522129 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.43894729 |
| 55 | T lymphocytopenia (HP:0005403) | 2.43761684 |
| 56 | Acanthocytosis (HP:0001927) | 2.41034950 |
| 57 | Hyperextensible skin (HP:0000974) | 2.38530772 |
| 58 | Spinal rigidity (HP:0003306) | 2.36945155 |
| 59 | Biconcave vertebral bodies (HP:0004586) | 2.36354149 |
| 60 | Intrahepatic cholestasis (HP:0001406) | 2.36329515 |
| 61 | Turricephaly (HP:0000262) | 2.36109179 |
| 62 | Myositis (HP:0100614) | 2.31336404 |
| 63 | Short 4th metacarpal (HP:0010044) | 2.30787767 |
| 64 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.30787767 |
| 65 | Joint laxity (HP:0001388) | 2.30663697 |
| 66 | Cellulitis (HP:0100658) | 2.29168855 |
| 67 | Increased connective tissue (HP:0009025) | 2.28857468 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.28469829 |
| 69 | Abnormality of chloride homeostasis (HP:0011422) | 2.27938910 |
| 70 | Hypolipoproteinemia (HP:0010981) | 2.27831696 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.26057341 |
| 72 | Ulnar bowing (HP:0003031) | 2.23821683 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.21729965 |
| 74 | Spondylolisthesis (HP:0003302) | 2.21145238 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.19293555 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.18920412 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17070261 |
| 78 | Conjugated hyperbilirubinemia (HP:0002908) | 2.16838736 |
| 79 | Glomerulosclerosis (HP:0000096) | 2.16210098 |
| 80 | Abnormality of the peritoneum (HP:0002585) | 2.15329925 |
| 81 | Hyperactive renin-angiotensin system (HP:0000841) | 2.14795684 |
| 82 | Proximal tubulopathy (HP:0000114) | 2.13569523 |
| 83 | Chronic diarrhea (HP:0002028) | 2.12398974 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.12351706 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.12351706 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 2.12351706 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09448036 |
| 88 | Cerebral aneurysm (HP:0004944) | 2.09396939 |
| 89 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.08878000 |
| 90 | Mitral valve prolapse (HP:0001634) | 2.08776988 |
| 91 | Emphysema (HP:0002097) | 2.08408791 |
| 92 | Pigmentary retinal degeneration (HP:0001146) | 2.07571655 |
| 93 | Recurrent fungal infections (HP:0002841) | 2.06859280 |
| 94 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.04753515 |
| 95 | Cervical subluxation (HP:0003308) | 2.04634310 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 2.04195797 |
| 97 | Coronal craniosynostosis (HP:0004440) | 2.03826797 |
| 98 | Deep venous thrombosis (HP:0002625) | 2.01181147 |
| 99 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99724193 |
| 100 | Recurrent abscess formation (HP:0002722) | 1.98107680 |
| 101 | Abdominal distention (HP:0003270) | 1.97414003 |
| 102 | Gout (HP:0001997) | 1.96769799 |
| 103 | Hypoplasia of the thymus (HP:0000778) | 1.95397886 |
| 104 | Hypoplasia of the uterus (HP:0000013) | 1.95090757 |
| 105 | Hyperammonemia (HP:0001987) | 1.94634135 |
| 106 | Fragile skin (HP:0001030) | 1.94170308 |
| 107 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.93858541 |
| 108 | Short hallux (HP:0010109) | 1.91703311 |
| 109 | Aneurysm (HP:0002617) | 1.90513551 |
| 110 | Obstructive sleep apnea (HP:0002870) | 1.89504504 |
| 111 | Vascular calcification (HP:0004934) | 1.89319947 |
| 112 | Hypoplastic labia majora (HP:0000059) | 1.88747823 |
| 113 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.88434424 |
| 114 | Ketoacidosis (HP:0001993) | 1.86694494 |
| 115 | Bowel diverticulosis (HP:0005222) | 1.86467003 |
| 116 | Neonatal short-limb short stature (HP:0008921) | 1.85870942 |
| 117 | Knee flexion contracture (HP:0006380) | 1.85588014 |
| 118 | Persistence of primary teeth (HP:0006335) | 1.84454043 |
| 119 | Hypoplastic ischia (HP:0003175) | 1.83432297 |
| 120 | Abnormality of skull ossification (HP:0002703) | 1.83029189 |
| 121 | Retrobulbar optic neuritis (HP:0100654) | 1.82939484 |
| 122 | Optic neuritis (HP:0100653) | 1.82939484 |
| 123 | Disproportionate tall stature (HP:0001519) | 1.82128610 |
| 124 | Abnormality of the 4th metacarpal (HP:0010012) | 1.80519538 |
| 125 | Recurrent bacterial skin infections (HP:0005406) | 1.80396658 |
| 126 | Abnormality of macrophages (HP:0004311) | 1.79423859 |
| 127 | Gingival bleeding (HP:0000225) | 1.78971167 |
| 128 | Follicular hyperkeratosis (HP:0007502) | 1.78704104 |
| 129 | Mitral stenosis (HP:0001718) | 1.77675677 |
| 130 | Ketosis (HP:0001946) | 1.77151281 |
| 131 | Polycythemia (HP:0001901) | 1.76510031 |
| 132 | Hepatoblastoma (HP:0002884) | 1.76282478 |
| 133 | Alopecia of scalp (HP:0002293) | 1.75898581 |
| 134 | Shawl scrotum (HP:0000049) | 1.75861878 |
| 135 | Ectopia lentis (HP:0001083) | 1.75169979 |
| 136 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.74515131 |
| 137 | Tibial bowing (HP:0002982) | 1.74490668 |
| 138 | Biliary tract neoplasm (HP:0100574) | 1.74202164 |
| 139 | Ovoid vertebral bodies (HP:0003300) | 1.73834735 |
| 140 | Mitral regurgitation (HP:0001653) | 1.73308270 |
| 141 | Striae distensae (HP:0001065) | 1.73215150 |
| 142 | Epidermoid cyst (HP:0200040) | 1.72559110 |
| 143 | Bell-shaped thorax (HP:0001591) | 1.72494335 |
| 144 | Dehydration (HP:0001944) | 1.72298057 |
| 145 | Redundant skin (HP:0001582) | 1.71835836 |
| 146 | Eosinophilia (HP:0001880) | 1.71832769 |
| 147 | Abnormality of the ischium (HP:0003174) | 1.71270988 |
| 148 | Abnormality of dentin (HP:0010299) | 1.71173194 |
| 149 | Neonatal hypoglycemia (HP:0001998) | 1.71156141 |
| 150 | Spastic diplegia (HP:0001264) | 1.70989003 |
| 151 | Long toe (HP:0010511) | 1.70683129 |
| 152 | Subcapsular cataract (HP:0000523) | 1.69513155 |
| 153 | Hypoproteinemia (HP:0003075) | 1.69444667 |
| 154 | Aortic regurgitation (HP:0001659) | 1.69425347 |
| 155 | Nephrolithiasis (HP:0000787) | 1.69106854 |
| 156 | Subacute progressive viral hepatitis (HP:0006572) | 1.68728008 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.67578736 |
| 158 | Hyperuricemia (HP:0002149) | 1.67202531 |
| 159 | Increased purine levels (HP:0004368) | 1.67202531 |
| 160 | Cutaneous finger syndactyly (HP:0010554) | 1.67137280 |
| 161 | Abnormality of nucleobase metabolism (HP:0010932) | 1.67105863 |
| 162 | Nonimmune hydrops fetalis (HP:0001790) | 1.66965196 |
| 163 | Hypoplastic nipples (HP:0002557) | 1.66890812 |
| 164 | Thoracolumbar scoliosis (HP:0002944) | 1.66155163 |
| 165 | Hyperglycinemia (HP:0002154) | 1.65474653 |
| 166 | Elbow flexion contracture (HP:0002987) | 1.64424553 |
| 167 | Abnormal glucose tolerance (HP:0001952) | 1.63526292 |
| 168 | Myocardial infarction (HP:0001658) | 1.62685950 |
| 169 | Severe short stature (HP:0003510) | 1.61088545 |
| 170 | Abnormality of the acetabulum (HP:0003170) | 1.60122894 |
| 171 | Chondrocalcinosis (HP:0000934) | 1.58695422 |
| 172 | Abnormal delivery (HP:0001787) | 1.57801283 |
| 173 | Syringomyelia (HP:0003396) | 1.57457226 |
| 174 | Spinal cord lesions (HP:0100561) | 1.57457226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.48466264 |
| 2 | LATS1 | 4.40591372 |
| 3 | STK39 | 3.70603642 |
| 4 | AKT3 | 3.61285540 |
| 5 | DDR2 | 3.33687021 |
| 6 | MST4 | 3.18216063 |
| 7 | SIK1 | 3.11879896 |
| 8 | OXSR1 | 3.00324085 |
| 9 | PRKD3 | 2.99218595 |
| 10 | EPHA2 | 2.86197056 |
| 11 | LMTK2 | 2.85584918 |
| 12 | MAP2K3 | 2.59792320 |
| 13 | PRKD2 | 2.20374275 |
| 14 | RIPK4 | 2.09780064 |
| 15 | RIPK1 | 2.01380421 |
| 16 | PDGFRA | 2.00189066 |
| 17 | EPHA3 | 1.95492967 |
| 18 | FER | 1.95339333 |
| 19 | ERN1 | 1.95131850 |
| 20 | TYK2 | 1.88451782 |
| 21 | MST1R | 1.79458252 |
| 22 | FGFR2 | 1.75705412 |
| 23 | EPHB2 | 1.72319347 |
| 24 | PTK6 | 1.71716921 |
| 25 | WNK4 | 1.67972426 |
| 26 | CDK12 | 1.66009072 |
| 27 | IRAK4 | 1.64967576 |
| 28 | CAMK1D | 1.59767696 |
| 29 | ACVR1B | 1.55369382 |
| 30 | MET | 1.55302642 |
| 31 | STK38L | 1.52817954 |
| 32 | STK3 | 1.51886472 |
| 33 | TRIB3 | 1.47170112 |
| 34 | KSR2 | 1.46152086 |
| 35 | BLK | 1.43044519 |
| 36 | TNK2 | 1.40667187 |
| 37 | SMG1 | 1.37306454 |
| 38 | MAP3K6 | 1.35889782 |
| 39 | NUAK1 | 1.34579665 |
| 40 | BCKDK | 1.32151423 |
| 41 | PRPF4B | 1.28718521 |
| 42 | MAP3K2 | 1.27077914 |
| 43 | PDK2 | 1.20929686 |
| 44 | ZAP70 | 1.17486501 |
| 45 | CSK | 1.16188491 |
| 46 | JAK3 | 1.15854076 |
| 47 | SCYL2 | 1.12892483 |
| 48 | CDC42BPA | 1.12434714 |
| 49 | LATS2 | 1.11856671 |
| 50 | WNK3 | 1.11479398 |
| 51 | MAP3K13 | 1.11265593 |
| 52 | PDK4 | 1.11223453 |
| 53 | PDK3 | 1.11223453 |
| 54 | KIT | 1.08653177 |
| 55 | TTN | 1.07447559 |
| 56 | MAP3K1 | 1.05840702 |
| 57 | PAK4 | 1.01660100 |
| 58 | LRRK2 | 1.01181408 |
| 59 | PTK2 | 0.98085626 |
| 60 | TAOK1 | 0.97077633 |
| 61 | YES1 | 0.95842488 |
| 62 | CAMK1G | 0.94615713 |
| 63 | TGFBR2 | 0.94281204 |
| 64 | TEC | 0.93689125 |
| 65 | NLK | 0.91068164 |
| 66 | SGK2 | 0.87988050 |
| 67 | STK10 | 0.87660119 |
| 68 | ICK | 0.86891245 |
| 69 | WNK1 | 0.84785020 |
| 70 | FGFR1 | 0.84615281 |
| 71 | ERBB2 | 0.83790051 |
| 72 | HCK | 0.82340752 |
| 73 | CDK6 | 0.81377165 |
| 74 | BTK | 0.81273388 |
| 75 | TAOK3 | 0.80875808 |
| 76 | PRKG2 | 0.80781050 |
| 77 | MOS | 0.80608993 |
| 78 | PIK3CA | 0.80248266 |
| 79 | BMX | 0.79329143 |
| 80 | MAP3K10 | 0.75739378 |
| 81 | MYLK | 0.73474818 |
| 82 | INSRR | 0.73302570 |
| 83 | MTOR | 0.73173916 |
| 84 | FGFR4 | 0.71404451 |
| 85 | PDGFRB | 0.70329963 |
| 86 | MAP3K7 | 0.68853125 |
| 87 | PKN2 | 0.68591742 |
| 88 | IRAK1 | 0.67814927 |
| 89 | DYRK1B | 0.66592886 |
| 90 | RPS6KA2 | 0.65786676 |
| 91 | MAPK7 | 0.65692686 |
| 92 | MARK2 | 0.65411476 |
| 93 | TBK1 | 0.64611658 |
| 94 | NEK9 | 0.63688595 |
| 95 | PRKAA2 | 0.62925512 |
| 96 | FGFR3 | 0.62165918 |
| 97 | PRKCH | 0.61997676 |
| 98 | PAK2 | 0.61994500 |
| 99 | MAP2K4 | 0.61056400 |
| 100 | PDK1 | 0.61029558 |
| 101 | HIPK2 | 0.59547319 |
| 102 | MAP4K1 | 0.58258482 |
| 103 | GRK1 | 0.57680254 |
| 104 | RPS6KL1 | 0.57312036 |
| 105 | RPS6KC1 | 0.57312036 |
| 106 | MAP3K14 | 0.56415439 |
| 107 | EPHB1 | 0.55832128 |
| 108 | SGK3 | 0.54070692 |
| 109 | MAP3K11 | 0.53858499 |
| 110 | PRKCI | 0.53457599 |
| 111 | MAP3K5 | 0.52433865 |
| 112 | GSK3A | 0.52387874 |
| 113 | EEF2K | 0.52030321 |
| 114 | PTK2B | 0.51760054 |
| 115 | IRAK2 | 0.51713669 |
| 116 | ROCK1 | 0.50689722 |
| 117 | LYN | 0.50594789 |
| 118 | STK38 | 0.49714374 |
| 119 | JAK1 | 0.49134467 |
| 120 | IKBKE | 0.48127959 |
| 121 | SYK | 0.45571807 |
| 122 | GRK5 | 0.45445783 |
| 123 | TYRO3 | 0.45138529 |
| 124 | DMPK | 0.45083420 |
| 125 | RPS6KA6 | 0.44595224 |
| 126 | TAOK2 | 0.44564106 |
| 127 | PRKAA1 | 0.38493637 |
| 128 | MAP3K8 | 0.37270730 |
| 129 | MAP2K1 | 0.36999864 |
| 130 | PAK3 | 0.36657439 |
| 131 | AKT2 | 0.34338770 |
| 132 | ERBB4 | 0.33344833 |
| 133 | CDK7 | 0.32544363 |
| 134 | INSR | 0.32223809 |
| 135 | PIK3CG | 0.31737994 |
| 136 | RET | 0.30883095 |
| 137 | MAP2K2 | 0.30304762 |
| 138 | NTRK1 | 0.30216819 |
| 139 | TRPM7 | 0.28301109 |
| 140 | NEK1 | 0.27492701 |
| 141 | PDPK1 | 0.26732138 |
| 142 | TTK | 0.26191099 |
| 143 | MELK | 0.25422891 |
| 144 | MAP3K3 | 0.23984223 |
| 145 | SRC | 0.23736043 |
| 146 | GRK6 | 0.22650767 |
| 147 | IGF1R | 0.19595438 |
| 148 | TESK1 | 0.19155651 |
| 149 | PRKCZ | 0.18826915 |
| 150 | MAPK11 | 0.18408124 |
| 151 | EGFR | 0.18326774 |
| 152 | JAK2 | 0.17389325 |
| 153 | PRKD1 | 0.16944535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.01022216 |
| 2 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 2.61284334 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.51333415 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.41567530 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38931822 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.31725623 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.27206376 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.22262932 |
| 9 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.14746405 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14614060 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12160786 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06091839 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.04158263 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03994598 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98915754 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97239963 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90343070 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.89599613 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.85184696 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.80634879 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76538045 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69438781 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.64583859 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63666083 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.63230382 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.52450675 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48559021 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44291171 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40829593 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37158564 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36897269 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36704801 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.34207308 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.33772558 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32619035 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31343725 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30697156 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27456887 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.25067380 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.24750109 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20279798 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.20236522 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18855337 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16489507 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.16390654 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15732023 |
| 47 | Adherens junction_Homo sapiens_hsa04520 | 1.15606676 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15385714 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14529669 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13090588 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11475062 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.10242254 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09878758 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09634777 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09271555 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09115882 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05767628 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04933546 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.04117127 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03190910 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99758791 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98189178 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97735101 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96602643 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95833266 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95827702 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95653045 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.95100794 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91625743 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91523672 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.89026189 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.89015173 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87300866 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86596737 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86437716 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.86057930 |
| 77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85755589 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85483193 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83275760 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82091055 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81235700 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80970274 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.80790309 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79934357 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79408051 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79176480 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78757818 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78204614 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78140313 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77293517 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76682522 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76372192 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.76030106 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74596474 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73240135 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72632531 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72332537 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71774546 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71623917 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.71613905 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69681355 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.68865643 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.68617689 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68527478 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68522577 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67510452 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67491166 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.67162706 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.65722342 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62462510 |
| 111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62393686 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61983391 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61804829 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.59727381 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59317198 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58997342 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.58918088 |
| 118 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58674294 |
| 119 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57078002 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56873339 |
| 121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56524604 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56352039 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55784603 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55596345 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54401902 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52789472 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52676926 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52620048 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.52140371 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50083960 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49875320 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49182216 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48462168 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.47536750 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47169937 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.44998989 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43576842 |
| 138 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42105144 |
| 139 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39324515 |
| 140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38489444 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37340222 |
| 142 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37107025 |
| 143 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37062729 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36850391 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33969802 |
| 146 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33866578 |
| 147 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32174083 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27683516 |
| 149 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.26224896 |
| 150 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23127590 |
| 151 | Melanoma_Homo sapiens_hsa05218 | 0.22671524 |
| 152 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.22599009 |

